Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of some unusual options trading activity on Thursday. Stock traders bought 2,173 put options on the stock. This is an increase of approximately 581% compared to the typical daily volume of 319 put options.

Several research firms have commented on HSIC. UBS Group reissued a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Piper Jaffray Companies upgraded shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Jefferies Group restated a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research report on Friday, October 20th. Robert W. Baird set a $95.00 price objective on shares of Henry Schein and gave the company a “buy” rating in a research report on Thursday, October 19th. Finally, Stifel Nicolaus restated a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research report on Thursday, October 19th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $86.21.

In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.19% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Henry Schein by 3.0% in the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after buying an additional 236,862 shares during the period. FMR LLC boosted its holdings in shares of Henry Schein by 0.4% in the second quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after buying an additional 24,935 shares during the period. BlackRock Inc. boosted its holdings in shares of Henry Schein by 1.8% in the second quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after buying an additional 101,406 shares during the period. Alecta Pensionsforsakring Omsesidigt boosted its holdings in shares of Henry Schein by 112.0% in the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after buying an additional 2,806,990 shares during the period. Finally, Mackenzie Financial Corp boosted its holdings in shares of Henry Schein by 106.0% in the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock worth $322,896,000 after buying an additional 2,026,867 shares during the period. Institutional investors own 91.69% of the company’s stock.

Henry Schein (HSIC) opened at $69.88 on Tuesday. Henry Schein has a 12-month low of $65.28 and a 12-month high of $93.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The firm has a market cap of $11,070.00, a PE ratio of 20.14, a PEG ratio of 1.97 and a beta of 0.99.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the consensus estimate of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the previous year, the business earned $0.84 earnings per share. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. sell-side analysts expect that Henry Schein will post 3.6 earnings per share for the current year.

Henry Schein declared that its Board of Directors has approved a stock repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to purchase up to 6.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/02/henry-schein-target-of-unusually-high-options-trading-hsic.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.